The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

Folr2  -  folate receptor 2 (fetal)

Mus musculus

Synonyms: FBP2, FR-P3, FR-beta, Fbp2, Folate receptor 2, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Folr2

 

High impact information on Folr2

  • Folbp2-/- embryos developed normally, but Folbp1-/- embryos had severe morphogenetic abnormalities and died in utero by embryonic day (E) 10 [5].
  • RESULTS: FRbeta-expressing cells were not present in peripheral blood leukocytes and their activated cells [4].
  • The results of Northern analyses using probes specific to FBP2 5'-untranslated sequences or to a splice junction within this region suggest that the up-regulated FBP2-specific message in F2-MTXrA utilizes 5'-noncoding sequences distinct from those used in the message encoded in L1210 cell lines with low level FBP2 expression [6].
  • The large increase in FBP2 expression in the F2-MTXrA line correlates with a 10-fold increase in [3H]folic acid membrane surface binding and a 1000-fold decrease in the folic acid growth requirement compared with parental L1210 cells [6].
  • Substitution of the amino-terminal portion (residues 1-92) in the mature FR-alpha polypeptide with the corresponding segment of FR-beta resulted in folate binding characteristics similar to FR-beta [7].
 

Chemical compound and disease context of Folr2

 

Biological context of Folr2

  • The present study identifies the critical amino acid sequence divergence underlying functional differences between FR-alpha and FR-beta [7].
  • Reciprocal substitution in FR-beta with peptide 1-92 of FR-alpha resulted in poor expression of a [3H]folic acid binding protein [7].
  • As the chromosomal locations of Folbp1 murine and Folbp2 genes were previously unknown, we utilized the same approach and mapped both genes to a region of mouse chromosome 7 that is syntenic to the human FR loci on chromosome 11q13 [9].
  • Contrary to expectations, studies on 24-h urinary speciation of sodium arsenate did not demonstrate any significant difference in arsenic biotransformation between Folbp2-/- and Folbp2+/+ mice [10].
  • Increased FR-beta expression in these cells can be induced by all-trans retinoic acid (ATRA) and other retinoid compounds in the absence of terminal differentiation or cell growth inhibition [11].
 

Anatomical context of Folr2

  • Compared to parental L1210 cells, expression of the FBP2-encoding transcript was unchanged in this cell line and, while the exact nature of the protein is unclear, FBP2 may represent a fetal form of the FBP [12].
  • Chimeric constructs of the cDNAs encoding human FR-alpha and FR-beta were expressed in human 293 fibroblasts [7].
  • The expression of mRNA of FR-beta was dominant in bone marrow cells of CIA mice [13].
  • Similar to FR-alpha (KB cells) and FR-beta (placenta), the protein was released from the membrane by phosphatidylinositol-specific phospholipase C, indicating a glycosylphosphatidylinositol (GPI) membrane anchor [14].
 

Associations of Folr2 with chemical compounds

 

Regulatory relationships of Folr2

  • RESULTS: Folbp2(-/-) mice had higher VPA-induced frequencies of embryonic lethality and exencephaly than did the wild-type control mice during folate supplementation and a control diet, respectively [3].

References

  1. Increased expression and characterization of two distinct folate binding proteins in murine erythroleukemia cells. Brigle, K.E., Spinella, M.J., Westin, E.H., Goldman, I.D. Biochem. Pharmacol. (1994) [Pubmed]
  2. Differential effects of arsenic on folate binding protein 2 (Folbp2) null and wild type fibroblasts. Crandall, L.Z., Vorce, R.L. Toxicol. Lett. (2002) [Pubmed]
  3. Valproate-induced neural tube defects in folate-binding protein-2 (Folbp2) knockout mice. Spiegelstein, O., Merriweather, M.Y., Wicker, N.J., Finnell, R.H. Birth defects research. Part A, Clinical and molecular teratology. (2003) [Pubmed]
  4. Effectiveness of anti-folate receptor beta antibody conjugated with truncated Pseudomonas exotoxin in the targeting of rheumatoid arthritis synovial macrophages. Nagayoshi, R., Nagai, T., Matsushita, K., Sato, K., Sunahara, N., Matsuda, T., Nakamura, T., Komiya, S., Onda, M., Matsuyama, T. Arthritis Rheum. (2005) [Pubmed]
  5. Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Piedrahita, J.A., Oetama, B., Bennett, G.D., van Waes, J., Kamen, B.A., Richardson, J., Lacey, S.W., Anderson, R.G., Finnell, R.H. Nat. Genet. (1999) [Pubmed]
  6. Increased expression and genomic organization of a folate-binding protein homologous to the human placental isoform in L1210 murine leukemia cell lines with a defective reduced folate carrier. Brigle, K.E., Seither, R.L., Westin, E.H., Goldman, I.D. J. Biol. Chem. (1994) [Pubmed]
  7. Identification of amino acid residues that determine the differential ligand specificities of folate receptors alpha and beta. Shen, F., Zheng, X., Wang, J., Ratnam, M. Biochemistry (1997) [Pubmed]
  8. Arsenic-induced congenital malformations in genetically susceptible folate binding protein-2 knockout mice. Wlodarczyk, B., Spiegelstein, O., Gelineau-van Waes, J., Vorce, R.L., Lu, X., Le, C.X., Finnell, R.H. Toxicol. Appl. Pharmacol. (2001) [Pubmed]
  9. Identification of two putative novel folate receptor genes in humans and mouse. Spiegelstein, O., Eudy, J.D., Finnell, R.H. Gene (2000) [Pubmed]
  10. Developmental consequences of in utero sodium arsenate exposure in mice with folate transport deficiencies. Spiegelstein, O., Gould, A., Wlodarczyk, B., Tsie, M., Lu, X., Le, C., Troen, A., Selhub, J., Piedrahita, J.A., Salbaum, J.M., Kappen, C., Melnyk, S., James, J., Finnell, R.H. Toxicol. Appl. Pharmacol. (2005) [Pubmed]
  11. Receptor induction and targeted drug delivery: a new antileukaemia strategy. Ratnam, M., Hao, H., Zheng, X., Wang, H., Qi, H., Lee, R., Pan, X. Expert opinion on biological therapy. (2003) [Pubmed]
  12. Characterization of two cDNAs encoding folate-binding proteins from L1210 murine leukemia cells. Increased expression associated with a genomic rearrangement. Brigle, K.E., Westin, E.H., Houghton, M.T., Goldman, I.D. J. Biol. Chem. (1991) [Pubmed]
  13. LY309887, antifolate via the folate receptor suppresses murine type II collagen-induced arthritis. Nagayoshi, R., Nakamura, M., Ijiri, K., Yoshida, H., Komiya, S., Matsuyama, T. Clinical and experimental rheumatology. (2003) [Pubmed]
  14. Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity. Shen, F., Ross, J.F., Wang, X., Ratnam, M. Biochemistry (1994) [Pubmed]
 
WikiGenes - Universities